1. Significant increase of synchronous disease in first-line metastatic colorectal cancer trials: Results of a systematic review
   Kaitlyn K.H. Goey et al, 2016, European Journal of Cancer CrossRef
2. Metadherin expression and lung relapse in patients with colorectal carcinoma
   Sandra Casimiro et al, 2014, Clinical & Experimental Metastasis CrossRef
3. Organ preservation in rectal cancer: current status and future perspectives
   Dirk Vande Putte et al, 2015, Colorectal Cancer CrossRef
4. Prognostic value of nomogram based on pre-treatment inflammatory markers in patients with pulmonary-only synchronous metastases from colorectal cancer
   Linyan Chen et al, 2019, International Immunopharmacology CrossRef
5. Clinical outcomes of Chinese patients with metastatic colorectal cancer receiving first-line bevacizumab-containing treatment
   Long Bai et al, 2015, Medical Oncology CrossRef
6. Tumor Biology and Natural History
   Daniele Fanale et al, 2021, Practical Medical Oncology Textbook CrossRef
7. Nationwide comparative study of synchronous and metachronous spine metastasis in the adult Korean population
   Seil Sohn et al, 2018, Journal of Clinical Neuroscience CrossRef
8. Surgical treatment of pulmonary metastasis in colorectal cancer patients: Current practice and results
   Matthieu Zellweger et al, 2018, Critical Reviews in Oncology/Hematology CrossRef
9. The different clonal origins of metachronous and synchronous metastases
   Ofer N. Gofrit et al, 2023, Journal of Cancer Research and Clinical Oncology CrossRef
10. Occurrence and survival of synchronous pulmonary metastases in colorectal cancer: A nationwide cohort study
    Andreas Nordholm-Carstensen et al, 2014, European Journal of Cancer CrossRef
11. Predictive factors for time to recurrence, treatment and post-recurrence survival in patients with initially resected colorectal liver metastases
    Jon-Helge Angelsen et al, 2015, World Journal of Surgical Oncology CrossRef
12. Progress in Rectal Cancer Treatment
    Wim P. Ceelen, 2012, ISRN Gastroenterology CrossRef
13. Stereotactic body radiotherapy for patients with oligometastases from colorectal cancer: risk-adapted dose prescription with a maximum dose of 83–100 Gy in five fractions
    Atsuya Takeda et al, 2016, Journal of Radiation Research CrossRef
14. Predictors and outcome of complete removal of colorectal cancer with synchronous lung metastases
    HIROAKI NOZAWA et al, 2015, Molecular and Clinical Oncology CrossRef
15. Emergency resection surgery for colorectal cancer: Patterns of recurrent disease and survival
    Joe Littlechild et al, 2018, World Journal of Gastrointestinal Pathophysiology CrossRef